Females | Males | p value | |
---|---|---|---|
Subjects (n) | 31 | 42 | |
Age (years)a | 78 ± 9 | 71 ± 9 | 0.001 |
Body weight (kg)a | 70 ± 16 | 83 ± 13 | 0.004 |
Sampling time after the acute stroke (days)a | 2.4 ± 1.6 | 2.0 ± 1.3 | NS |
Cardiogenic stroke (n) | 8 | 6 | NS |
Small artery disease (n) | 14 | 24 | NS |
Large artery disease (n) | 9 | 12 | NS |
Recurrent stroke (n) | 6 | 15 | NS |
Current smokers (n) | 3 | 7 | NS |
Diabetes (n) | 2 | 9 | NS |
Hypertension (n) | 11 | 21 | NS |
Previous myocardial infarction (n) | 2 | 5 | NS |
A2-Blockers (n) | 1 | 3 | NS |
ACE-inhibitors (n) | 13 | 4 | 0.001 |
Aspirin 75 mg (n) | 11 | 19 | NS |
β-Blockers (n) | 10 | 11 | NS |
Ca2+-Blockers (n) | 6 | 9 | NS |
Clopidogrel (n) | 0 | 0 | NS |
Diuretics (n) | 5 | 9 | NS |
Statins (n) | 4 | 11 | NS |
Vitamin K antagonists (n) | 1 | 5 | NS |